The picture shows doctor gives a vaccine dose to a patient. — Reuters/File

Moderna and Merck have said that their mRNA cancer vaccine, when combined with Merck’s widely used immunotherapy, cut the risk of melanoma death or recurrence by 42% in a large trial, potentially…